Health Care/Hospital
Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China
HANGZHOU, China, Feb. 24, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new–generation cAMP–biased GLP–1 receptor agonist. Under the agree...
2026-02-24 13:14
4681
HSI Donesafe and Neopharma Technologies Announce API Integration for Fit-For-Duty Workflows
SYDNEY, Feb. 24, 2026 /PRNewswire/ -- Many organisations have invested heavily in safety management systems, yet Fit-For-Duty controls are still handled separately or measured inconsistently. Drug and alcohol programs often sit outside core safety platforms, while functional impairment from fatig...
2026-02-24 09:10
3675
NYSE Content Update: Stock Market to Open Like Normal Amid Historic NYC Blizzard
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...
2026-02-23 22:04
7067
ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options
Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate – whether as a standalone cloud application or as an integrated extension of ZEISS FORUM – enabling secure data sharing, structured referrals, and real-time clinical coord...
2026-02-23 22:00
6554
"Would You Clone Yourself for a Cure?" Clonell Unveils White Paper on Fundamental Cures for 34 Incurable Diseases Using 'Human Cloning' Technology
Harnessing the vitality of a clone while neutralizing ethical controversies through a breakthrough 'Therapeutic Cloning' protocol—ushering in a new era of regenerative medicine to conquer cancer, Alzheimer's, and aging. YONGIN, South Korea, Feb. 23, 2026 /PRNewswire/ -- Human cloning has long be...
2026-02-23 21:40
3582
iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson's and First Enrollment in China's Randomized MSA Trial for NouvNeu004
CHENGDU, China, Feb. 23, 2026 /PRNewswire/ -- The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical stages in the U.S. andChina. Concurrently, the company's "AI + Chemical Induction" platform saw its...
2026-02-23 21:00
5015
Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, Feb. 23, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd. ("Arrotex"), for exclusive rights to the commercialization of clobetasol propio...
2026-02-23 14:00
5439
Herbalife Announces Cristiano Ronaldo Invests $7.5 Million in Pro2col™ Technology, Acquires 10% Equity Stake
Long-time partner invests in shared vision for personalized health and wellness HONG KONG, Feb. 23, 2026 /PRNewswire/ -- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, announced global sports icon Cristiano Ronaldo acquired a 10% equity interest in HBL ...
2026-02-23 12:00
7980
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
BANGKOK, Feb. 23, 2026 /PRNewswire/ -- With a remarkable 30% growth in size and participation, Vitafoods Asia 2026 organised by Informa Markets, is set to redefine the nutraceutical industry in Asia, offering unparalleled opportunities for innovation and collaboration. The event will feature an ...
2026-02-23 10:09
6655
CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC
* Following approval by the European Commission (EC), sugemalimab has received a new indication approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for stage III non-small cell lung cancer (NSCLC). This marks the second indication approved for the product in the UK. ...
2026-02-23 08:10
6005
HeyGears Announces One-Piece Denture Solution - Redefining Digital Dentures with Dual-Material 3D Printing
HeyGears' One-Piece Denture Solution enables dual-material denture DLP 3D printing, seamlessly fusing denture base and teeth materials in a single printing process to deliver more natural aesthetics and a comfortable fit. CHICAGO, Feb. 20, 2026 /PRNewswire/ -- HeyGears announces breakthrough One...
2026-02-20 22:00
9690
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December 31, 2025. FY 2025 key results1 Group performance2: Double-digit revenue growth and positive adju...
2026-02-20 07:27
13065
Indian, Regional, and Global Partners Launch Initiatives to Address Extreme Heat in South Asia
The World Health Organization (WHO)–World Meteorological Organization (WMO) Climate and Health Joint Programme, The Rockefeller Foundation, and Wellcome announce new regional efforts to connect climate science to health action to prevent heat impacts, help communities flourish, and save lives. M...
2026-02-20 04:56
7886
TraceLink Named to RXinsider's 2026 Pharmacy500 for Powering Digital Network Orchestration Across the Regulated Pharmacy Supply Chain
The recognition highlights TraceLink's Business-to-Network Integrate-Once™ platform that enables end-to-end digitalization, interoperable compliance execution, and operational resilience at industry scale Summary TraceLink is recognized for delivering a unified, network-based platform that help...
2026-02-19 23:00
8632
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful development of a premium anti-aging facial mask incorpor...
2026-02-19 22:00
9409
3Shape Boosts Dental Lab Speed and Accuracy with AI-Powered Workflows
COPENHAGEN, Denmark, Feb. 19, 2026 /PRNewswire/ -- At LMT LabDay today, 3Shape showcases its AI-powered and integrated workflows that help dental labs work faster, reduce errors, and handle more cases efficiently. A reliable bite setup in seconds Scans from intraoral scanners can sometimes inclu...
2026-02-19 21:07
6900
Cambrex Announces Cornell Professor Song Lin as Recipient of the 2025 Snapdragon Prize for Innovation in Chemistry Technology
EAST RUTHERFORD, N.J., Feb. 19, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) and Snapdragon Chemistry, a Cambrex company, are proud to announce that Dr. Song Lin, Tisch University Professor in chemistry and chemical biology at Cornell U...
2026-02-19 19:00
6865
A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
Japan's Ministry of Health, Labour and Welfare (MHLW) Approves
PreemieFort® Enteral Solution asPrescription Medicine in the NICU
DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ -- Prolacta Bioscience®
2026-02-19 05:03
6409
Lifespan Vision Ventures Co-Leads Sift Biosciences' $3.7M Pre-Seed Financing
NORWALK, Conn., Feb. 19, 2026 /PRNewswire/ -- Lifespan Vision Ventures, an investment firm focused on therapeutics that improve human healthspan, today announced that it has co-led Sift Biosciences' oversubscribed $3.7 million Pre-Seed financing alongside Freeflow Ventures, with participation fro...
2026-02-19 01:00
4750
Datasea Announces Foundational Research Breakthrough in Ultrasonic-Enhanced Nanoscale Precision Control
Establishing an Engineering-Level Core Technology for Next-Generation Semiconductor Manufacturing Applications BEIJING, Feb. 18, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based technology company specializing in acoustic high-tech solutions and 5G+AI ...
2026-02-18 22:30
9022
Week's Top Stories
Most Reposted
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 286 media titles]
2026-05-26 10:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15ISDN's IDI Dynamics debuts high-speed laser marker for semiconductor assembly and test (OSAT)
[Picked up by 280 media titles]
2026-05-26 08:40
Consistently recognised: Infobip named a Leader in Gartner® Magic Quadrant™ for CPaaS again
[Picked up by 279 media titles]
2026-05-21 16:31
Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
8128
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
7920
